Graben-Neudorf, Germany

Helmut Ponta

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Weingarten, AT (2015)
  • Graben-Neudorf, DE (2014 - 2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Helmut Ponta: Innovator in Cancer Treatment

Introduction

Helmut Ponta is a notable inventor based in Graben-Neudorf, Germany. He has made significant contributions to the field of cancer treatment, particularly in developing innovative peptides for combating pancreatic cancer. With a total of 5 patents to his name, Ponta's work is recognized for its potential impact on medical therapies.

Latest Patents

Among his latest patents, Ponta has developed CD44v6-derived peptides for treating metastasizing cancer. This invention relates to compounds, pharmaceutical compositions, and methods aimed at treating various forms of pancreatic cancer. Another significant patent focuses on CD44v6-derived peptides specifically for treating pancreatic cancer, showcasing his dedication to addressing this critical health issue.

Career Highlights

Throughout his career, Helmut Ponta has worked with esteemed organizations such as Amcure GmbH and the Karlsruhe Institute of Technology. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ponta has collaborated with notable colleagues, including Alexandra Matzke and Veronique Orian-Rousseau. These partnerships have further enriched his research and development efforts in cancer treatment.

Conclusion

Helmut Ponta's innovative work in developing peptides for cancer treatment highlights his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the fight against pancreatic cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…